Massachusetts Financial Firm Trims Elevance Health Stock Position

Institutional investor reduces stake in major health insurance provider

Apr. 11, 2026 at 10:37am

Got story updates? Submit your updates here. ›

An extreme close-up of a complex network of industrial gears and levers, representing the complex financial infrastructure of the healthcare industry.A filing by a major institutional investor reveals shifting dynamics in the healthcare insurance market.Indianapolis Today

Massachusetts Financial Services Co. MA, a major institutional investor, has reduced its holdings in Elevance Health, Inc. (NYSE: ELV) by 3.3% during the fourth quarter, according to a recent SEC filing. The firm now owns approximately 2.36 million shares of the health insurance company's stock, worth around $827.6 million.

Why it matters

This move by a prominent institutional investor provides insight into the market's sentiment towards Elevance Health, one of the largest health benefits providers in the United States. Shifts in ownership by major funds can signal broader trends in the healthcare sector and investor confidence in the company's performance.

The details

According to the 13F filing, Massachusetts Financial Services Co. MA sold 79,772 shares of Elevance Health during the fourth quarter, reducing its total position to 2,360,858 shares. The firm now owns about 1.06% of Elevance Health's outstanding stock. The filing indicates the reduction was part of broader portfolio adjustments made by the investment management firm.

  • The 13F filing covers the fourth quarter of 2025.
  • The shares were sold between October 1 and December 31, 2025.

The players

Massachusetts Financial Services Co. MA

A major institutional investment management firm based in Boston, Massachusetts.

Elevance Health, Inc.

A large U.S. health benefits company that provides a broad range of insurance products and related services, headquartered in Indianapolis.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Elevance Health's institutional ownership, even if relatively small, could signal broader market concerns about the company's outlook or the healthcare sector in general. Investors will likely monitor Elevance's performance and any further changes in major shareholder positions.